The Science of Survivorship from a Personal Perspective
NCI is dedicated to science at the highest level: research that leads to effective interventions with reduced toxicity; diagnosis at earlier, more treatable stages; and prevention strategies based on a molecular understanding of carcinogenesis and targeted interventions. But our mission to reduce the burden of cancer doesn't end there. A vital component of NCI's research focuses on America's growing population of cancer survivors, who now number more than 10 million, up from only 3 million in 1971.
For a great many patients, cancer's effects continue long after treatment is completed. Consequently, NCI's survivorship science, under the leadership of the Office of Cancer Survivorship (OCS), seeks to understand, for example, why two patients with strikingly similar tumors may face starkly different possibilities of future disease recurrence. We also track and study the experiences of former patients in order to obtain deeper knowledge about the posttreatment effects of cancer drugs and devices. And we seek answers about how patients can better cope with the emotional and financial pressures that may result from successful treatment. Read more
OCS Hosts Cancer Survivorship Research Conference
At this year's biennial cancer survivorship research conference, "Cancer Survivorship: Embracing the Future," held October 4-6 at the Bethesda Marriott Hotel in Bethesda, Md., more than 400 people gathered to discuss the state of the science for cancer survivorship.
"Survivors often find their ordeal transformed into an experience of growth and self-realization," explained Ellen Stovall, president and CEO of the National Coalition for Cancer Survivorship, during her opening address. "They can try to help others by leaving them hints as to how to survive." Read more